You can buy or sell Vaxart and other stocks, options, and ETFs commission-free!
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA. The listed name for VXRT is Vaxart, Inc Common Stock.
South San Francisco, California
52 Week High
52 Week Low
— per share
-$0.13 per share